AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 59,100
-5,500 (-8.51%)
At close: Feb 6, 2026
AprilBio Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 8,974 | 27,514 | - | 200 | 23,396 | - | |
Revenue Growth (YoY) | -56.67% | - | - | -99.15% | - | - |
Cost of Revenue | 19.2 | 16.38 | 19.05 | 26.27 | 19.21 | 14.55 |
Gross Profit | 8,955 | 27,498 | -19.05 | 173.73 | 23,377 | -14.55 |
Selling, General & Admin | 4,866 | 6,654 | 4,582 | 4,054 | 4,490 | 1,995 |
Research & Development | 4,937 | 3,205 | 8,038 | 6,925 | 13,892 | 6,781 |
Amortization of Goodwill & Intangibles | 0.72 | 0.68 | 0.68 | 0.67 | 0.61 | 0.61 |
Other Operating Expenses | 74.73 | 63.2 | 74.54 | 75.96 | 61.16 | 35.47 |
Operating Expenses | 10,570 | 10,629 | 13,369 | 11,648 | 18,930 | 9,173 |
Operating Income | -1,615 | 16,869 | -13,388 | -11,474 | 4,446 | -9,188 |
Interest Expense | -824.83 | -1,420 | -930.54 | -29.78 | -2,114 | -1,277 |
Interest & Investment Income | 3,572 | 3,312 | 3,149 | 1,309 | 262.92 | 67.28 |
Currency Exchange Gain (Loss) | 1,441 | 2,121 | 93.21 | 1,086 | -161.7 | - |
Other Non Operating Income (Expenses) | -3,328 | -754.03 | -3,028 | 149.97 | -55,147 | 47.15 |
EBT Excluding Unusual Items | -754.83 | 20,128 | -14,104 | -8,959 | -52,713 | -10,350 |
Gain (Loss) on Sale of Assets | - | -0 | -25.87 | -0.01 | - | 5.64 |
Other Unusual Items | -122.8 | -122.8 | - | - | - | - |
Pretax Income | -877.63 | 20,005 | -14,130 | -8,959 | -52,713 | -10,344 |
Income Tax Expense | - | - | - | - | - | -124.05 |
Net Income | -877.63 | 20,005 | -14,130 | -8,959 | -52,713 | -10,220 |
Net Income to Common | -877.63 | 20,005 | -14,130 | -8,959 | -52,713 | -10,220 |
Shares Outstanding (Basic) | 23 | 22 | 21 | 20 | 8 | 3 |
Shares Outstanding (Diluted) | 23 | 22 | 21 | 20 | 8 | 3 |
Shares Change (YoY) | 3.94% | 2.66% | 9.11% | 134.61% | 139.04% | 400.04% |
EPS (Basic) | -39.00 | 913.04 | -662.00 | -458.00 | -6322.00 | -2930.00 |
EPS (Diluted) | -39.00 | 913.04 | -662.00 | -458.00 | -6322.00 | -2930.00 |
Free Cash Flow | 3,145 | 21,514 | -10,571 | -6,794 | 2,546 | -7,774 |
Free Cash Flow Per Share | 139.75 | 981.92 | -495.25 | -347.29 | 305.34 | -2228.70 |
Gross Margin | 99.79% | 99.94% | - | 86.87% | 99.92% | - |
Operating Margin | -18.00% | 61.31% | - | -5737.15% | 19.00% | - |
Profit Margin | -9.78% | 72.71% | - | -4479.64% | -225.31% | - |
Free Cash Flow Margin | 35.05% | 78.19% | - | -3396.76% | 10.88% | - |
EBITDA | -923.76 | 17,575 | -12,714 | -10,881 | 4,934 | -8,826 |
EBITDA Margin | -10.29% | 63.88% | - | - | 21.09% | - |
D&A For EBITDA | 691.58 | 706.33 | 674.42 | 593.44 | 487.25 | 361.36 |
EBIT | -1,615 | 16,869 | -13,388 | -11,474 | 4,446 | -9,188 |
EBIT Margin | -18.00% | 61.31% | - | - | 19.00% | - |
Advertising Expenses | - | - | - | 14.33 | 3.5 | 8 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.